- PYRIMIDINE AND QUINAZOLINE DERIVATIVES
-
This invention is concerned with compounds of the formula ( l ) wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
- -
-
Page/Page column 80-81
(2008/06/13)
-
- PYRIDINE, QUINOLINE AND PYRIMIDINE DERIVATIVES
-
This invention is concerned with compounds of the formula wherein A, R1 to R5 are as defined in the specification and G is a pyridine, quinoline or pyrimidine group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
- -
-
Page/Page column 34
(2008/06/13)
-
- BENZOIMIDAZOLE, TETRAHYDRO-QUINOXALINE, BENZOTRIAZOLE, DIHYDRO-IMIDAZO[4,5-c] PYRIDINONE AND DIHYDRO-ISOINDOLONE DERIVATIVES
-
This invention relates to compounds of the formula wherein A, R1 to R3 are as defined in the specification and G is benzoimidazole, quinoxaline, benzotriazole, dihydro-imidazo[4,5-c]pyridine and dihydro-isoindolone group as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
- -
-
Page/Page column 29
(2008/12/08)
-
- 4,4-DISUBSTITUTED PIPERIDINE DERIVATIVES
-
This invention relates to 4,4-disubstituted piperidine derivatives of the formula wherein A and R1 to R5 are as defined in the specification, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceuti
- -
-
Page/Page column 18
(2009/01/20)
-
- Pyrimidine, quinazoline, pteridine and triazine derivatives
-
This invention is concerned with compounds of the formula wherein A, R1 to R5 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
- -
-
Page/Page column 42
(2008/06/13)
-
- BENZOOXAZOLE, OXAZOLOPYRIDINE, BENZOTHIAZOLE AND THIAZOLOPYRIDINE DERIVATIVES
-
This invention is concerned with compounds of the formula (I) wherein X, A, B, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical
- -
-
Page/Page column 91; 101
(2008/06/13)
-
- Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives
-
This invention is concerned with compounds of the formula wherein A, B1, B2, R1, R2 and G are as defined in the description and claims, and pharmaceutically acceptable salts thereof. The invention further relates to pharmaceutical compositions containing such compounds, to a process for their preparation and to their use for the treatment and/or prevention of diseases which are associated with the modulation of SST receptors subtype 5.
- -
-
Page/Page column 27
(2010/11/23)
-
- Compositions containing aromatic aldehydes and their use in treatments
-
Disclosed are pharmaceutical and cosmetic compositions containing aromatic aldehyde compounds. Some of the disclosed compositions are useful as topical therapeutics for treating inflammatory dermatologic conditions. Some of the compositions are useful in transdermal and other systemic dose forms for treating other inflammatory conditions in mammals.
- -
-
-
- 3-Alkoxy Substituted Oligo- and Poly(1,4-phenyleneethenylene)s
-
The 3-alkoxy-4-methylbenzaldehydes (3a-e) can be obtained by alkylation of the hydroxy compound 1.Reaction with aniline yields the azomethines (4a-e) which enter in an alkaline medium a polycondensation to the title compounds 5a-e.Contrary to the 2-substituted educts, a competitive intramolecular condensation process is principally not possible.Benzoylation of 1 furnisches 3f.However, the corresponding Schiff base 4 f is not capable of a condensation reaction because the ester group is cleaved.
- Kretzschmann, H.,Meier, H.
-
p. 255 - 259
(2007/10/02)
-